Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease

[1]  S. Mishiro,et al.  Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates , 1998, Archives of Virology.

[2]  T. Uchida,et al.  Mutations of the X region of hepatitis B virus and their clinical implications , 1997, Pathology international.

[3]  S. Mishiro,et al.  The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. , 1995, The Journal of general virology.

[4]  M. Moriyama,et al.  Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B , 1995, Journal of medical virology.

[5]  O. Andrisani,et al.  The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Okamoto,et al.  Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis , 1995, Annals of Internal Medicine.

[7]  F Tsuda,et al.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen , 1994, Journal of virology.

[8]  L. Ting,et al.  Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome , 1994, Journal of virology.

[9]  C. Yuh,et al.  Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus , 1992, Journal of virology.

[10]  O. Yokosuka,et al.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. , 1991, The New England journal of medicine.

[11]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[12]  A. Zuckerman,et al.  Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. , 1991, Journal of hepatology.

[13]  C. Yuh,et al.  The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function , 1990, Journal of virology.

[14]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[15]  Y. Wang,et al.  A new enhancer element, ENII, identified in the X gene of hepatitis B virus , 1990, Journal of virology.

[16]  M. Levrero,et al.  Mapping of B-cell epitopes of the human hepatitis B virus X protein , 1990, Journal of virology.

[17]  F Tsuda,et al.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.

[18]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[19]  Brunetto.  Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis , 1989 .

[20]  H. Sakugawa,et al.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. , 1988, The Journal of general virology.